CXCL12/CXCR4 Blockade Alleviates LPS-Induced Abortion by Regulating the Balance of Th17/Treg Cells in Mice

被引:0
作者
Hao, Xiaoying [1 ]
Gao, Caihong [1 ]
Xiao, Yuanyuan [1 ]
Jia, Huifeng [1 ]
Yu, Jingjing [1 ]
Tian, Xiaoqing [1 ]
Hou, Yongli [1 ]
机构
[1] Shanxi Med Univ, Dept Obstet & Gynecol, Hosp 2, Taiyuan 030001, Shanxi, Peoples R China
关键词
abortion; chemokine ligand 12; chemokine receptor 4; T helper (Th)17/regulatory T (Treg) balance; lipopolysaccharide; TH17; CELLS; HUMAN PLACENTA; EXPRESSION; CHEMOKINES;
D O I
10.23812/j.biol.regul.homeost.agents.20233703.137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) and T helper (Th)17/regulatory T (Treg) cells are reportedly involved in the immune response during pregnancy. The aim of this study was to investigate the effect of CXCL12/CXCR4 on Th17/Treg balance in a mouse model of lipopolysaccharide (LPS)-induced abortion. Methods: Abortion was induced by injection of LPS and AMD3100 was used to block CXCL12/CXCR4. The fetus absorption rates and spleen index were calculated, and hematoxylin and eosin staining was carried out. Quantitative reverse transcriptase-polymerase chain reaction was employed to determine the expression levels of chemokine ligand 12 (CXCL12), CXC receptor 4 (CXCR4), interleukin 17 (IL-17), IL-6, IL-21, IL-22, IL-2, IL-10, retinoid-related orphan nuclear receptor-gamma t (ROR gamma t), interferon-gamma (IFN-gamma), forkhead box P3 (Foxp3), and transforming growth factor-beta (TGF-beta). Protein levels of CXCL12 and CXCR4 were determined, using western blot analysis. Flow cytometry was applied to quantify IL-17 and Foxp3 expression levels. Results: AMD3100 significantly reversed the higher levels of CXCL12 and CXCR4, fetus absorption rates, and spleen indices induced by LPS (p < 0.05). Histopathological examination showed that decidual integrity was damaged and the trophoblasts were thinner after LPS treatment, which were blocked by AMD3100. Immunohistochemistry (IHC) analysis revealed that AMD3100 significantly attenuated Th17 infiltration but significantly promoted Foxp3 expression. AMD3100 significantly downregulated the proportion of Th17 cells and significantly upregulated that of Treg cells in the peripheral blood and spleen. Besides, the expression levels of Th17-related cytokines (IL-17, ROR gamma t, IFN-gamma, IL-6, IL-21 and IL-22) were significantly downregulated, while Treg-related cytokines (Foxp3, TGF-beta, IL-2 and IL-10) were significantly upregulated by AMD3100. Conclusions: The inhibition of C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) could alleviate the miscarriage in LPS-induced abortion by regulating the balance of Th17/Treg cells in mice. These findings may provide a promising strategy for the clinical management of recurrent miscarriage.
引用
收藏
页码:1371 / 1380
页数:10
相关论文
共 41 条
  • [1] A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia
    Agostinis, Chiara
    Zito, Gabriella
    Toffoli, Miriam
    Peterlunger, Isabel
    Simoni, Livia
    Balduit, Andrea
    Curtolo, Erica
    Mangogna, Alessandro
    Belmonte, Beatrice
    Vacca, Davide
    Romano, Federico
    Stampalija, Tamara
    Salviato, Tiziana
    Defendi, Federica
    Di Simone, Nicoletta
    Kishore, Uday
    Ricci, Giuseppe
    Bulla, Roberta
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] CXCL12 in normal and pathological pregnancies: A review
    Ao, Deng
    Li, Da-Jin
    Li, Ming-Qing
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2020, 84 (03)
  • [3] BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
    Bockorny, Bruno
    Semenisty, Valerya
    Macarulla, Teresa
    Borazanci, Erkut
    Wolpin, Brian M.
    Stemmer, Salomon M.
    Golan, Talia
    Geva, Ravit
    Borad, Mitesh J.
    Pedersen, Katrina S.
    Park, Joon Oh
    Ramirez, Robert A.
    Abad, David G.
    Feliu, Jaime
    Munoz, Andres
    Ponz-Sarvise, Mariano
    Peled, Amnon
    Lustig, Tzipora M.
    Bohana-Kashtan, Osnat
    Shaw, Stephen M.
    Sorani, Ella
    Chaney, Marya
    Kadosh, Shaul
    Haras, Abi Vainstein
    Von Hoff, Daniel D.
    Hidalgo, Manuel
    [J]. NATURE MEDICINE, 2020, 26 (06) : 878 - +
  • [4] Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis
    Burska, Agata N.
    Thu, Aye
    Parmar, Rekha
    Bzoma, Izabella
    Samans, Bjoern
    Raschke, Eva
    Olek, Sven
    Conaghan, Philip G.
    Emery, Paul
    Ponchel, Frederique
    [J]. RHEUMATOLOGY, 2019, 58 (11) : 2015 - 2024
  • [5] CXCL12 expression in aborted mouse uteri induced by IFN-γ: Potential anti-inflammatory effect involves in endometrial restoration after abortion in mice
    Chao, Hu-He
    Li, Lin
    Gao, Xiao
    Wang, Chengrong
    Yue, Wentao
    [J]. GENE, 2019, 700 : 38 - 46
  • [6] ATP6V1G3 Acts as a Key Gene in Recurrent Spontaneous Abortion: An Integrated Bioinformatics Analysis
    Chen, Yihong
    Hu, Jifen
    [J]. MEDICAL SCIENCE MONITOR, 2020, 26
  • [7] Effects of Bisphenol A and 4-tert-Octylphenol on Embryo Implantation Failure in Mouse
    Dinh Nam Tran
    Jung, Eui-Man
    Ahn, Changhwan
    Lee, Jae-Hwan
    Yoo, Yeong-Min
    Jeung, Eui-Bae
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (08):
  • [8] Reciprocal chemokine receptor and ligand expression in the human placenta: Implications for cytotrophoblast differentiation
    Drake, PM
    Red-Horse, K
    Fisher, SJ
    [J]. DEVELOPMENTAL DYNAMICS, 2004, 229 (04) : 877 - 885
  • [9] MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
    Ghasemi, Kimia
    Ghasemi, Kosar
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [10] HMGB1/CXCL12-Mediated Immunity and Th17 Cells Might Underlie Highly Suspected Autoimmune Epilepsy in Elderly Individuals
    Han, Yuxiang
    Yang, Liling
    Liu, Xiaoyun
    Feng, Yabo
    Pang, Zaiying
    Lin, Youting
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 1285 - 1293